Home / Politics / Policy /  Supreme Court refuses to hear challenge on NPPA decision

New Delhi: The Supreme Court on Monday refused to entertain a petition challenging a decision by the country’s drug price regulator to withdraw its internal guideline to set prices of non-essential drugs.

Earlier this year, the National Pharmaceutical Pricing Authority (NPPA) issued a guideline empowering itself to cap the prices of 108 non-essential drugs, attracting criticism from the industry. It was withdrawn on 22 September, after a directive by the government’s department of pharmaceuticals. Lawyer M.L. Sharma had filed a public interest litigation against the withdrawal, saying the decision could lead to a rise in the prices of certain drugs as it would allow “pharmaceuticals companies to raise price as per their choice to secure windfall gain".

A bench headed by chief justice H.L. Dattu, however, asked Sharma to withdraw his petition and approach the central government with a representation, as it was government policy.

The petition was filed in earlier this month when the apex court had said it would hear the case “as early as possible".

A similar petition was also filed before the Delhi high court by the All India Drug Action Network (AIDAN).

Catch all the Politics News and Updates on Live Mint. Download The Mint News App to get Daily Market Updates & Live Business News.
More Less
Recommended For You
Get alerts on WhatsApp
Set Preferences My ReadsWatchlistFeedbackRedeem a Gift CardLogout